News for ARS Pharmaceuticals Inc Stock (SPRY)

The Schall Law Firm Is Looking Into Whether ARS Pharmaceuticals Inc Committed Securities Law Violations And Stockholders Are Urged To Join The Investigation

Accesswire • 09/05/24

ARS Pharmaceuticals Inc. May Have Defrauded The Public And The Schall Law Firm Wants Impacted Investors To Reach Out About An Inquiry

Accesswire • 09/04/24

The Schall Law Firm Is Looking Into Whether ARS Pharmaceuticals Inc Committed Securities Related Infractions And Shareholders Are Urged To Help

Accesswire • 09/03/24

ARS Pharmaceuticals Inc. May Have Violated Securities Laws And The Schall Law Firm Seeks Investor Participation In An Inquiry

Accesswire • 09/02/24

Shareholders Are Encouraged By The Schall Law Firm To Be A Part Of An Investigation Into ARS Pharmaceuticals Inc For Potential Securities Fraud

Accesswire • 09/01/24

ARS Pharmaceuticals Inc. Might Have Committed Securities Law Violations And The Schall Law Firm Wants Investors To Partake In An Inquiry

Accesswire • 08/31/24

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc's Potential Securities Fraud And Affected Shareholders Are Encouraged To Reach Out

Accesswire • 08/30/24

ARS Pharmaceuticals Inc. Is Being Investigated For Securities Related Impropriety And Investors Should Contact The Schall Law Firm

Accesswire • 08/29/24

The Schall Law Firm Invites Shareholders To Partake In An Inquiry Into ARS Pharmaceuticals Inc For Securities Fraud

Accesswire • 08/28/24

ARS Pharmaceuticals Inc Is Being Investigated For Securities Law Infractions And Investors Can Join The Schall Law Firm In The Inquiry

Accesswire • 08/27/24

Shareholders Should Reach Out To The Schall Law Firm About A Securities Fraud Inquiry Into ARS Pharmaceuticals Inc

Accesswire • 08/26/24

EURneffy (adrenaline nasal spray) Approved in the EU as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

GlobeNewsWire • 08/26/24

ARS Pharmaceuticals Inc Is Being Investigated For Securities Law Violations And Investors Are Encouraged To Contact The Schall Law Firm

Accesswire • 08/25/24

A Securities Fraud Inquiry Into ARS Pharmaceuticals Inc Has Been Opened By The Schall Law Firm And Shareholders Are Invited To Join

Accesswire • 08/24/24

The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc For Potential Securities Law Violations And Investors With Losses Are Urged To Reach Out

Accesswire • 08/23/24

ARS Pharmaceuticals Inc Is Being Looked Into By The Schall Law Firm For Possible Securities Fraud And Affected Shareholders Are Invited To Help

Accesswire • 08/22/24

The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc For Potential Securities Law Violations And Investors Are Urged To Participate

Accesswire • 08/21/24

ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst

Benzinga • 08/20/24

The Schall Law Firm Is Inquiring Into ARS Pharmaceuticals Inc's Possible Securities Law Violations And Shareholders Are Invited To Help

Accesswire • 08/20/24

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc's Potential Securities Violations And Investors Are Urged To Join

Accesswire • 08/19/24

The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc. And Investors Are Encouraged To Join

Accesswire • 08/18/24

The Schall Law Firm Investigates ARS Pharmaceuticals Inc. And Shareholders Are Invited To Join

Accesswire • 08/17/24

The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc. And Affected Investors Are Encouraged To Join

Accesswire • 08/16/24

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc. And Harmed Investors Are Encouraged To Join

Accesswire • 08/15/24

ARS Pharmaceuticals Inc. Is Being Investigated By The Schall Law Firm, And Affected Investors Are Urged To Engage In Dialogue

Accesswire • 08/15/24